Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-32
Closed 433
2022
Q4
$0 Hold
32
﹤0.01% 513
2022
Q3
$0 Buy
+32
New +$315 ﹤0.01% 511
2021
Q4
Sell
-24
Closed 415
2021
Q3
$0 Buy
24
+12
+100% +$170 ﹤0.01% 379
2021
Q2
$0 Sell
12
-121
-91% -$1.75K ﹤0.01% 394
2021
Q1
$2K Sell
133
-4,501
-97% -$73.4K ﹤0.01% 360
2020
Q4
$87K Buy
4,634
+4,414
+2,006% +$72K 0.03% 174
2020
Q3
$3K Hold
220
﹤0.01% 313
2020
Q2
$4K Hold
220
﹤0.01% 371
2020
Q1
$3K Hold
220
﹤0.01% 306
2019
Q4
$4 Buy
+220
New +$4.09K ﹤0.01% 293

Other funds holding VTRS

Leelyn Smith's VTRS Position: Q1 2023 in Review

Leelyn Smith sold out of Viatris (VTRS) in Q1 2023, closing a stake of 32 shares.

Leelyn Smith first reported a position in VTRS in Q4 2019 and held it in 10 quarters. The position peaked at $87K in Q4 2020. 988 funds tracked by Wall St. Rank hold VTRS as of Q1 2023.

  • Leelyn Smith reported no remaining Viatris position as of Q1 2023 after selling out during the quarter.
  • Leelyn Smith sold 32 Viatris shares in Q1 2023.
  • Leelyn Smith first reported a position in Viatris in Q4 2019 and held it in 10 quarters.
  • Leelyn Smith's Viatris position peaked at $87K in Q4 2020.
  • 988 funds tracked by Wall St. Rank held Viatris as of Q1 2023.

Based on Leelyn Smith's 13F filing for Q1 2023, filed 12 May 2023.